Compare 10X Genomics Inc (TXG) vs Vanguard Total International Stock Index Fund ETF (VXUS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
10X Genomics Inc vs Vanguard Total International Stock Index Fund ETF — how do they compare? 10X Genomics Inc trades at $46.82 (market cap $5.48B), while Vanguard Total International Stock Index Fund ETF trades at $84.5. The key difference: 10X Genomics Inc is trading nearer its 52-week high, Vanguard Total International Stock Index Fund ETF nearer its low. Which is the better fit depends on your goals.
| TXG | VXUS | |
|---|---|---|
Market Cap | $5.48B | — |
Sector | Health | Sector/Thematic |
52-Week High | $45.80 | $87.06 |
52-Week Low | $11.34 | $68.24 |
Enterprise Value | $5.02B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →About Vanguard Total International Stock Index Fund ETF
VXUS is a comprehensive, low-cost ETF that tracks the FTSE Global All Cap ex US Index, providing exposure to over 8,500 stocks in both developed and emerging markets outside the United States. It serves as a foundational building block for international diversification, allowing investors to own a market-cap-weighted slice of the entire non-U.S. investable equity universe in a single vehicle.
Read more on VXUS →
